3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gastrointestinal
1
Conditions
Breast Neoplasms
3
Support of the Family as a Caregiving System
1
Stomach Neoplasms
1
Otorhinolaryngologic Neoplasms
1
Mixed Dementias
1
Meningeal Carcinomatosis
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Localized Head and Neck Carcinoma
1
Lewy Body Disease
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Dementia, Vascular
1
Dementia
1
Cognitive Dysfunction
1
Cigarette Smoking-Related Carcinoma
1
Anxiety Disorders
1
Interventions
Fluorouracil
14
pembrolizumab
13
Paclitaxel
13
Oxaliplatin
13
Leucovorin
10
Carboplatin
9
Radiotherapy
8
Capecitabine
8
Trastuzumab
7
Nivolumab
7
Drug Therapy
7
Cisplatin
7
Radiation
6
Esophagectomy
6
Taxes
5
Specimen Handling
5
Surgical Procedures, Operative
4
Irinotecan
4
trastuzumab deruxtecan
3
tislelizumab
3
patritumab deruxtecan
3
Radiotherapy, Intensity-Modulated
3
Proton Therapy
3
Immunotherapy
3
Blood Specimen Collection
3
zanidatamab
2
ulixertinib
2
trastuzumab biosimilar HLX02
2
relatlimab
2
durvalumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Referral and Consultation
×
90 days
×
Clear all
NCT03102229
2026-04-13
RAMPART
Montefiore Medical Center
Phase NA
Completed
40 enrolled